Source:http://linkedlifedata.com/resource/pubmed/id/17322894
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-7
|
pubmed:abstractText |
Cardiac overstimulation by the sympathetic nervous system (SNS) is a salient characteristic of heart failure, reflected by elevated circulating levels of catecholamines. The success of beta-adrenergic receptor (betaAR) antagonists in heart failure argues for SNS hyperactivity being pathogenic; however, sympatholytic agents targeting alpha2AR-mediated catecholamine inhibition have been unsuccessful. By investigating adrenal adrenergic receptor signaling in heart failure models, we found molecular mechanisms to explain the failure of sympatholytic agents and discovered a new strategy to lower SNS activity. During heart failure, there is substantial alpha2AR dysregulation in the adrenal gland, triggered by increased expression and activity of G protein-coupled receptor kinase 2 (GRK2). Adrenal gland-specific GRK2 inhibition reversed alpha2AR dysregulation in heart failure, resulting in lowered plasma catecholamine levels, improved cardiac betaAR signaling and function, and increased sympatholytic efficacy of a alpha2AR agonist. This is the first demonstration, to our knowledge, of a molecular mechanism for SNS hyperactivity in heart failure, and our study identifies adrenal GRK2 activity as a new sympatholytic target.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrbk1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Adrbk1 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/G-Protein-Coupled Receptor Kinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Adrenergic Receptor Kinases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1078-8956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
315-23
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17322894-Adrenal Glands,
pubmed-meshheading:17322894-Adrenocortical Hyperfunction,
pubmed-meshheading:17322894-Animals,
pubmed-meshheading:17322894-Cells, Cultured,
pubmed-meshheading:17322894-G-Protein-Coupled Receptor Kinase 2,
pubmed-meshheading:17322894-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:17322894-Heart Failure,
pubmed-meshheading:17322894-Male,
pubmed-meshheading:17322894-Mice,
pubmed-meshheading:17322894-Mice, Transgenic,
pubmed-meshheading:17322894-Rats,
pubmed-meshheading:17322894-Rats, Sprague-Dawley,
pubmed-meshheading:17322894-Up-Regulation,
pubmed-meshheading:17322894-beta-Adrenergic Receptor Kinases
|
pubmed:year |
2007
|
pubmed:articleTitle |
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure.
|
pubmed:affiliation |
Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|